SPP1 and myeloid sarcoma: High levels of OPN in the CSF of MS patients was recently linked to a reduced brain volume and enlarged ventricles over a decade, but no relationship was observed with peripheral OPN levels, suggesting a key role of central nervous system-localized inflammation, mediated by OPN, in driving long-term brain damage [30].